Report - Roche Analyst Event · Ira Mellman, Ph.D., Vice President, Cancer Immunology, gRED Genentech ECC 2015 Roche cancer immunotherapy highlights: - Atezolizumab phase II bladder and lung

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form